XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Stocks fall, Nvidia down 3% after the bell despite strong earnings



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>GLOBAL MARKETS-Stocks fall, Nvidia down 3% after the bell despite strong earnings</title></head><body>

Wall Street indexes finish slightly lower

Nvidia's results beat analyst estimates

Dollar rebounds

Gold prices slip

Crude oil drops

Updates with prices throughout with U.S. markets close, adds Nvidia earnings and oil settlement, and new quote

By Chibuike Oguh and Lawrence White

NEW YORK/LONDON, Aug 28 (Reuters) -Global equity markets eased while the U.S. dollar rebounded on Wednesday, and then chipmakerNvidia'sbetter-than-expected results failed to impress some investors and the company's stock fell 3% in extended trading.

Wall Street's main indexes finished lower, theDow Jones Industrial Average .DJI fell 0.39% to 41,091.42, the S&P 500 .SPX lost 0.60% to 5,592.18 and the Nasdaq Composite .IXIC lost 1.12% to 17,556.03.

Europe's benchmark STOXX index .STOXX climbed 0.33% while Japanese stocks .N225 closed 0.22% higher. MSCI's gauge of all stocks across the globe .MIWD00000PUS was 0.42%lower at 827.32.

Nvidia NVDA.O's third-quarter revenue forecast of $32.5 billion surpassed Wall Street estimates after markets closed. The report still failed to impress the most bullish investors who have driven a dizzying rally in its shares as they bet billions on the future of generative artificial intelligence. Shares of the Santa Clara, California-based company fell 3% in extended trading.

Nvidia's stock price is up some 3,000% since 2019 and with a market capitalisation of $3 trillion, a move in its share price affects the broader market. It finished down 2% at $125.61 during regular hours trading.

"They beat the average estimates because they came in around $32 billion and average estimates were $31 billion but some people on the street have them up at like $37 billion revenue estimates," said Michael Ashley Schulman, chief investment officer at Running Point Capital in Los Angeles.

"I think you're seeing some disappointment on some bets but not really disappointment on the company."

A preliminary estimate of second quarter U.S. gross domestic product is due on Thursday. The Fed's preferred inflation measure - the core personal consumption expenditures (PCE) index - will be released on Friday.

Markets, which are fully priced for a 25 basis point U.S. interest rate cut next month, see just over 100 basis points of easing by the end of the year. FEDWATCH

The yield on benchmark U.S. 10-year Treasury notes US10YT=RR, which moves inversely to the price, rose 0.8 basis points to 3.841%.

"The good news is all pretty much priced in whether that be [Federal Reserve Chair Jerome]Powell's promise more or less to cut rates in September and the fact that we're now pricing a soft landing again," said David Spika, chief markets strategist at Turtle Creek Wealth Advisors in Dallas.

"The economic data has been supportive of the fact that the economy is not falling apart."

After a recent run of declines, the dollar was advancing. The dollar index =USD, which measures the greenback against a basket of currencies including the yen and the euro, gained 0.5% at 101.10, with the euro EUR= down 0.63% at $1.1114.

Gold prices were hurt by the stronger U.S. dollar with spot gold XAU= lost 0.68% to $2,507.50 an ounceand U.S. gold futures GCc1 settled 0.6% lower at $2,537.80.

Oil prices fell on concerns about Chinese demand and risks of a broader slowdown. Brent crude futures LCOc1 settled down 1.13% at $78.65 a barrel. U.S. West Texas Intermediate crude CLc1 futures fell 1.34% to $74.52.


World FX rates YTD http://tmsnrt.rs/2egbfVh

Global asset performance http://tmsnrt.rs/2yaDPgn


Reporting by Chibuike Oguh in New York and Lawrence White in London, Editing by Bernadette Baum, Kirsten Donovan and David Gregorio

To read Reuters Markets and Finance news, click on https://www.reuters.com/finance/markets
</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.